Refractory Ganglioneuroblastoma
1 clinical trials · Condition
◉ Watch Refractory Ganglioneuroblastoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse (NCT07437963) | National Cancer Institute (NCI) | 2026-10-28 |
Track Refractory Ganglioneuroblastoma automatically
Every clearance here is in the API, with alerts when new ones post.